To study soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis and the effects of anti-TNF treatment on biomarkers
Latest Information Update: 01 Jul 2020
At a glance
- Drugs Certolizumab pegol (Primary) ; Etanercept (Primary)
- Indications Ankylosing spondylitis; Rheumatoid arthritis
- Focus Pharmacodynamics
Most Recent Events
- 01 Jul 2020 New trial record
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism